Cargando…

OR18-04 Leptin Decreases Gluconeogenesis And Gluconeogenic Substrate Availability In Patients With Lipodystrophy

Disclosure: E. Quaye: None. S. Chacko: None. M. Startzell: None. R.J. Brown: Other; Self; Metreleptin for the study was donated by Amryt Pharma. Leptin is an adipocyte-derived hormone that signals overall energy sufficiency. In patients with lipodystrophy, treatment with recombinant leptin (metrelep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quaye, Emmanuel, Chacko, Shaji, Startzell, Megan, Brown, Rebecca J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Diabetes And Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556979/ http://dx.doi.org/10.1210/jendso/bvad114.896

Ejemplares similares

OR08-04 Differences in Advanced Lipoprotein Profile Between Rabson-Mendenhall Syndrome and Lipodystrophy
por: Al-Jundi, Mohammad, et al.
Publicado: (2020)

THU301 Natural History Of Pregnancy And Pregnancy Outcomes In Subjects With Lipodystrophy
por: Neal, Trinity J, et al.
Publicado: (2023)

Racial Disparities Among Clinical Trials for Inherited Forms of Lipodystrophy
por: Abel, Brent S, et al.
Publicado: (2021)

MON-159 Increased Gluconeogenesis and Lower Glycogenolysis in Patients with Non-Selective Compared Selective Insulin Resistance
por: Sekizkardes, Hilal, et al.
Publicado: (2019)

RF04 | PSUN333 Divergent Pathways in Liver Triglyceride Storage and Secretion in Partial Lipodystrophy vs. Obesity Associated NAFLD
por: Klein, Rachael, et al.
Publicado: (2022)

THU268 Hyperuricemia In Insulin Resistance Is Associated With Increased Synthesis And Not Decreased Renal Excretion Of Uric Acid In Humans
por: Haykal, Rasha, et al.
Publicado: (2023)

RF16 | PSUN335 Clinical Effects of Sodium Glucose Transporter Type 2 Inhibitors in Patients with Severe Insulin Resistance
por: Bansal, Rashika, et al.
Publicado: (2022)

LBODP052 A Novel Hnf4α Corepressor Irf2bp2: Its Role In The Gluconeogenic Gene Regulation Via Biochemically Labile Interaction
por: Kouketsu, Takumi, et al.
Publicado: (2022)

PSUN138 Demonstration of Progressive Beta-Cell Failure in Familial Partial Lipodystrophy
por: De Freitas, Maria Foss, et al.
Publicado: (2022)

Leptin Decreases Energy Expenditure but Increases Thyroid Hormone in Patients With Lipodystrophy
por: Quaye, Emmanuel, et al.
Publicado: (2021)

PSUN141 Suspected Lipodystrophy in a Thin Young Man With Type 1 Diabetes
por: Moats, Sarah, et al.
Publicado: (2022)

SAT089 Natural History Of Generalized Lipodystrophy Following Early Vs. Late Metreleptin Treatment
por: Brush, Maiah, et al.
Publicado: (2023)

SAT039 Chronic Glucocorticoid Exposure Induced A S1PR2-Rorc Axis To Enhance Hepatic Gluconeogenesis
por: Arwyn Lee, Rebecca, et al.
Publicado: (2023)

SAT090 Serum Ketone Levels Are Disproportionate To Beta-Oxidation In Insulin Receptor Mutation Compared Vs Lipodystrophy Patients
por: Klein, Rachael, et al.
Publicado: (2023)

MON-685 Lipodystrophy, a Forgotten Syndrome
por: Castellano, Janet Marie Colón, et al.
Publicado: (2020)

RF04 | PSUN233 Design of an Ultra-Stable Insulin/Glucagon Fusion Protein
por: Grabowski, Rachel, et al.
Publicado: (2022)

RF04 | PSUN295 Evolution of Monomeric Multi-Agonists of GLP-1 and NPY Receptors
por: Chichura, Kylie, et al.
Publicado: (2022)

SAT-183 Activating Transcription Factor 4 (ATF4) As A Possible Mediator Of Gluconeogenic And Lipogenic Actions Of Fat Mass And Obesity Associated (FTO) In Liver
por: Mizuno, Tooru, et al.
Publicado: (2019)

RF04 | PSUN135 Genetic Inactivation of Glutaminase Reduces Amino Acid Induced Alpha Cell Proliferation
por: Shou, Matthew, et al.
Publicado: (2022)

OR12-04 LEAP2 Deletion Does Not Counteract The Effects Of Ghrelin Deletion During Insulin-Induced-Hypoglycemia
por: Shankar, Kripa, et al.
Publicado: (2023)

RF04 | PSUN298 Loss of β-Cell Glut2 Does Not Affect Systemic Glucose Homeostasis in Mice
por: Bathina, Siresha, et al.
Publicado: (2022)

RF04 | PSUN133 Assessment of the Rnf20 Histone Modifier in Regulating Pancreatic Beta-Cell Identity and Function
por: Pierre, Tanya, et al.
Publicado: (2022)

RF04 | PSUN313 A Natural Antibody Against Oxidized Phospholipids Improves Glucose Metabolism in Aging Mice
por: Ambrogini, Elena, et al.
Publicado: (2022)

RF04 | PSUN334 Mineralocorticoid receptors mediate diet - induced lipid infiltration of skeletal muscle and insulin resistance
por: Habibi, Javad, et al.
Publicado: (2022)

Enhanced Insulin Signaling Through Its Receptor Is Needed for the Development of Hyperuricemia in Humans
por: Haykal, Rasha, et al.
Publicado: (2021)

MON-637 DREADD-Induced POMC(ARC)Neuron Activation Increases Fasting Plasma Glucose Levels Through Changes in Hepatic Gluconeogenic Gene Expression but Not Changes in the HPA Axis Activity
por: Vieira, Luane da Guia, et al.
Publicado: (2020)

RF04 | PSUN163 In High Glucose Exposed Endothelial Cells BTK is a Novel Component of the Nuclear Factor-Kappa B Pathway
por: Singh, Madhu, et al.
Publicado: (2022)

OR34-04 Defective FGFR1 Signaling Disrupts Glucose Regulation In Humans: Evidence From Patients With Isolated Hypogonadotropic Hypogonadism Harboring FGFR1 Mutations
por: Stamou, Maria, et al.
Publicado: (2023)

OR30-04 Autonomous Drone Delivery of Insulin
por: O’Keeffe, Derek Timothy, et al.
Publicado: (2020)

SAT-622 Heterogeneity of Familial Partial Lipodystrophy Type 2 from a Genotype-Phenotype Perspective
por: de Freitas, Maria Cristina Foss, et al.
Publicado: (2020)

RF04 | PSUN297 Genetic Knockout of Intestinal Hexokinase Domain Containing Protein-1 Affects Enterocyte Glucose Transport in Mice Fed High Fat Diet
por: Zapater, Joseph, et al.
Publicado: (2022)

OR12-06 Hypothalamic Adgrl1 Is A Potential Glucoreceptor Involved In Regulating Energy Balance, Glucose Homeostasis, And Leptin Sensitivity In Mice
por: Samuel, Dennis J, et al.
Publicado: (2023)

MON-155 A Patient with Acquired Generalized Lipodystrophy (AGL, Lawrence Syndrome) in Association with CTLA-4 Haploinsufficiency
por: Ozer, Muhammet, et al.
Publicado: (2019)

MON-695 Multiple Recurrent Lipomatoses with Thiazolidinedione Therapy in Familial Partial Lipodystrophy, Dunnigan Variety (FPLD2)
por: Patni, Nivedita, et al.
Publicado: (2020)

SUN-LB111 Comparison of Phenotype and Metabolic Abnormalities Among Familial Partial Lipodystrophy Due to LMNA or PPARG Variants
por: Vasandani, Chandna, et al.
Publicado: (2020)

SAT-153 Role Of Increased Serum- And Glucocorticoid-inducible Kinase 1 (SGK1) Activity In Gluconeogenesis And Liver Metabolism During Metabolic Syndrome.
por: Velazquez-Garcia, Silvia, et al.
Publicado: (2019)

SUN-LB032 Severe Insulin Resistance and Nephrotic Range Proteinuria Reversed by Pioglitazone in a Patient With Dunnigan Type Lipodystrophy
por: Sharma, Anjul, et al.
Publicado: (2019)

SUN-135 Dual Energy X-Ray Absorptiometry (DEXA) as a Diagnostic Tool for Familial Partial Lipodystrophy, Dunnigan Variety (FPLD2)
por: Vasandani, Chandna, et al.
Publicado: (2019)

SAT-617 Potential Utility of the Mixed Meal Test for Differential Diagnosis of Partial Lipodystrophy from Common Type 2 Diabetes and Truncal Obesity
por: Guraya, Armaan, et al.
Publicado: (2020)

OR14-04 A Novel ERRα-Dependent Insulin Signaling Pathway
por: Xia, Hui, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dg184vm0bhp12ecn4e70oeomln